Cardio Diagnostics Holdings Inc (CDIOW) is a pioneering company in the medical technology sector, focused on transforming cardiovascular care through state-of-the-art diagnostic solutions. Utilizing proprietary algorithms and advanced genetic testing, it enhances the accuracy of cardiovascular risk assessments, enabling personalized patient management. As a leader in the integration of data analytics and genomics, Cardio Diagnostics is ideally positioned to capitalize on the growing demand for precision medicine, driving improved clinical outcomes. With a strong commitment to advancing cardiovascular health, the company is poised for significant growth in an evolving healthcare environment.
| Revenue (TTM) | 14,820 |
| Gross Profit (TTM) | 14,820 |
| EBITDA | $-6.09M |
| Operating Margin | -41160.00% |
| Return on Equity | -78.60% |
| Return on Assets | -44.10% |
| Revenue/Share (TTM) | $0.01 |
| Book Value | $3.82 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -21.20% |
| Shares Outstanding | 0 |
| Float | $2.83M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |